Sort by
Refine Your Search
-
Department: Institute of Development Policy (IOB) Regime Full-time Let’s shape the future - University of Antwerp The University of Antwerp is a dynamic, forward-thinking, European university. We
-
Department: Center for Molecular Neurology Regime Full-time Let’s shape the future – University of Antwerp The Gut-Immune-Brain Axis Lab (Prof. Seppe De Schepper, VIB-UAntwerp) and the Brain and
-
of neuroscience. The PhD will be integrated in the Peripheral Neuropathy research group of Prof. Vincent Timmerman . About the project Charcot-Marie-Tooth neuropathy can be caused by mutations in different genes
-
of neuroscience. The PhD will be integrated in the Peripheral Neuropathy research group of Prof. Vincent Timmerman . About the project Charcot-Marie-Tooth neuropathy can be caused by mutations in different genes
-
into their workflows. You will benchmark the supports, MEMS devices and developed codes on known multiphased reference samples. The TEM will be done at EMAT (University of Antwerp) under guidance of Prof. Dr. Joke
-
. Opportunities of career development (doctoral training) A stimulating and international research environment; an opportunity to collaborate with leading research groups in Belgium and abroad. You will receive
-
for Contract Research Staff . Opportunities of career development (doctoral training) A stimulating and international research environment; an opportunity to collaborate with leading research groups in Belgium
-
plasma-/bio-/chemo-catalysts under the supervision of Professor Joke Hadermann. The PhD project is part of a broader research effort focused on developing innovative technologies for the sustainable
-
within the Antwerp University Hospital and the University of Antwerp, comprising over 50 scientists with a main goal to advance cancer treatment and to improve patient quality of life through development
-
/immunotherapies are insufficient due to resistance development and limited efficacy. Personalized medicine, focusing on novel prognostic and predictive biomarkers to identify patients that will respond to treatment